Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131474) titled 'A Single-Arm, Multicenter Exploratory Study of Zemtuzumab in Combination with Chemotherapy for Pediatric Recurrent and Refractory Tumors' on Sept. 2.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital,Sun Yat-sen University
Condition:
Recurrent/refractory tumors in children
Recruitment Status: Not Recruiting
Phase: 1
Date of First Enrollment: 2026-09-20
Target Sample Size: Treatment group:12;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=338782
Disclaimer: Curated by HT Syndication....